IMVT
Immunovant, Inc. · Healthcare
Director Douglas J. Hughes sold $349K of Immunovant, Inc.
Sold$348,665
$23.24Price
15,000Shares
−11%Stake
What IMVT did after the filing
- The stock from Thu, Dec 4 open, $22.55
- +15.9%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Mon, Dec 1. Filed Wed, Dec 3, 6:14 PM ET, after the close. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.